Literature DB >> 17752841

A Prothrombin Conversion Accelerator in Serum.

B Alexander, A de Vries, R Goldstein, G Landwehr.   

Abstract

Keywords:  BLOOD/prothrombin; SERUM

Mesh:

Substances:

Year:  1949        PMID: 17752841     DOI: 10.1126/science.109.2839.545

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  16 in total

1.  The hereditary haemorrhagic diseases: their classification and diagnosis.

Authors:  A J QUICK
Journal:  Br Med J       Date:  1959-04-25

2.  Biochemical genetics of blood coagulation.

Authors:  J B GRAHAM
Journal:  Am J Hum Genet       Date:  1956-06       Impact factor: 11.025

3.  Congenital factor VII deficiency; a review with a report of a case in an Indian infant.

Authors:  H COHEN; H C FALCKE; H B GREIG; M SIMON
Journal:  Arch Dis Child       Date:  1956-08       Impact factor: 3.791

4.  [New concepts on the mechanism of blood coagulation].

Authors:  R MARBET; A WINTERSTEIN
Journal:  Experientia       Date:  1954-07-15

5.  The control of anticoagulant therapy in myocardial infarction.

Authors:  R B HUNTER; W WALKER
Journal:  Br Med J       Date:  1954-07-24

6.  Partial purification of human prothrombin and proconvertin: their characteristics and interaction.

Authors:  J H LEWIS; J H FERGUSON
Journal:  J Clin Invest       Date:  1953-10       Impact factor: 14.808

7.  Physiopathological classification of the haemorrhagic diseases.

Authors:  P DE NICOLA
Journal:  Can Med Assoc J       Date:  1952-12       Impact factor: 8.262

Review 8.  Some Important Milestones in the Field of Blood Clotting.

Authors:  Russell F Doolittle
Journal:  J Innate Immun       Date:  2015-12-15       Impact factor: 7.349

9.  Prothrombin and haemorrhage.

Authors:  A C DONALD; R B HUNTER; G R TUDHOPE; W WALKER; I WHITTON
Journal:  Br Med J       Date:  1954-10-23

10.  On the comparative prothrombic activity of human and dog blood.

Authors:  A J QUICK; C V HUSSEY
Journal:  J Clin Invest       Date:  1951-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.